Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Finding the five-year window: A qualitative study examining young women's decision-making and experience of using tamoxifen to reduce BRCA1/2 breast cancer risk.

Psycho-oncology - 1 Feb 2021

Forrest Laura E, Forbes Shepherd Rowan, Young Mary-Anne, Keogh Louise A, James Paul A

Abstract excerpt

OBJECTIVE: Tamoxifen has been demonstrated to reduce breast cancer risk in high-risk, premenopausal women. Yet, very few young women with hereditary breast and ovarian cancer syndrome in Australia use tamoxifen, despite this being a less-invasive option compared to risk-reducing mastectomy. This study aims to examine young women's decision-making about and experience of taking tamoxifen to reduce their breast...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decision Making

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Qualitative Research

Share to Reproduction

Share to Tamoxifen

Source

Identifiers

PMID: 33006205
DOI: 10.1002/pon.5556

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Finding the five-year window: A qualitative study examining young women's decision-making and experience of using tamoxifen to reduce BRCA1/2 breast cancer risk.PMID 33006205Read ↗

Reproductive decision-making in young female carriers of a BRCA mutation.Semantic proximity Read ↗

In their own words: treating very young BRCA1/2 mutation-positive women with care and caution.Semantic proximity Read ↗

Anticipatory loss and early mastectomy for young female BRCA1/2 mutation carriers.Semantic proximity Read ↗

Longitudinal cancer risk management trajectories of BRCA1/2 mutation-positive reproductive-age women.Semantic proximity Read ↗

Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30.Semantic proximity Read ↗

Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.Semantic proximity Read ↗

Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer.Semantic proximity Read ↗

Preparing young people for future decision-making about cancer risk in families affected or at risk from hereditary breast cancer: A qualitative interview study.Semantic proximity Read ↗

A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.Semantic proximity Read ↗

Living with the BRCA genetic mutation: an uncertain conclusion to an unending process.Semantic proximity Read ↗

Being young, female, and BRCA positive.Semantic proximity Read ↗

Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.